Free Trial

ICON Public Q3 2023 Earnings Report

ICON Public logo
$207.51 +2.90 (+1.42%)
(As of 12/20/2024 05:31 PM ET)

ICON Public EPS Results

Actual EPS
$3.10
Consensus EPS
$3.10
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

ICON Public Revenue Results

Actual Revenue
$2.06 billion
Expected Revenue
$2.05 billion
Beat/Miss
Beat by +$5.85 million
YoY Revenue Growth
N/A

ICON Public Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

ICON Public Earnings Headlines

ICON plc Appoints Barry Balfe as Chief Operating Officer
ICON plc: ICON Announces Appointment of Chief Operating Officer
Crypto’s hidden gem + greatest crypto bull run in history = $$$?
You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.
ICON Announces Appointment of Chief Operating Officer
Icon (ICLR) Receives a Buy from Truist Financial
See More ICON Public Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ICON Public? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ICON Public and other key companies, straight to your email.

About ICON Public

ICON Public (NASDAQ:ICLR) Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

View ICON Public Profile

More Earnings Resources from MarketBeat

Upcoming Earnings